FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|Texas Lottery misled players in scratch-off game, lawsuit claims|
|A group of Texas lotto players who thought they struck it rich in a scratch-off game say the state unfairly deceived them in ambiguous language on the game card.|
|Northeast Ohio officer subdues high school student who brought loaded handgun to school|
|Police say an officer subdued a 15-year-old Ohio high school student who came to school armed with a loaded semi-automatic pistol.|
|US stocks open lower, following declines in Europe as US air strikes begin; CarMax sinks|
|U.S. stocks are opening lower following disappointing economic news and U.S.-led airstrikes against Islamic State militants in Syria.|
|Police take clothes from apartment of man thought to be last seen with missing UVa student|
|Officials have taken articles of clothing from the apartment of the man they believe was the last person seen with a missing University of Virginia student.|
|Miami U president supports skunk safety, accepts PETA offer for posters after stuck-can case|
|An Ohio college president says the school supports safety for skunks, and for other furry creatures, too.|
|Idaho woman faces felony after deputies say she chewed seat of patrol car|
|A northern Idaho woman has been charged with a felony after police say she chewed up the upholstery of a patrol car seat.|
|Secretary of State's remark raises issue whether Iraq, US could pursue militants into Syria|
|Secretary of State John Kerry told senators last week that a "right of hot pursuit" could provide a basis for military forces to move across the border between Iraq and Syria to strike at Islamic State militants.|
|Charges dropped against homeless man found in Pennsylvania hotel presidential suite|
|Prosecutors in western Pennsylvania have dropped charges against a homeless man found squatting inside the presidential suite of a Pittsburgh hotel last fall.|
|Police issue warrant for man believed last to see missing UVA student Hannah Graham|
|The man who police believe was the last person seen with the University of Virginia student who vanished on Sept.13 is being sought by police on two misdemeanor reckless driving warrants, but has not been heard from since Sunday.|
|Red Cross sets up shelters for families displaced during hunt for trooper-ambush suspect|
|A 10-day manhunt for the survivalist accused of ambushing a Pennsylvania State Police barracks has narrowed to the rural area where he grew up and his parents still live, but the suspect has managed to elude capture despite the efforts of hundreds of law enforcement officials.|